amiodarone has been researched along with Triple Negative Breast Neoplasms in 1 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Triple Negative Breast Neoplasms: Breast neoplasms that do not express ESTROGEN RECEPTORS; PROGESTERONE RECEPTORS; and do not overexpress the NEU RECEPTOR/HER-2 PROTO-ONCOGENE PROTEIN.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Gallyas, F | 1 |
Ramadan, FHJ | 1 |
Andreidesz, K | 1 |
Hocsak, E | 1 |
Szabo, A | 1 |
Tapodi, A | 1 |
Kiss, GN | 1 |
Fekete, K | 1 |
Bognar, R | 1 |
Szanto, A | 1 |
Bognar, Z | 1 |
1 other study available for amiodarone and Triple Negative Breast Neoplasms
Article | Year |
---|---|
Involvement of Mitochondrial Mechanisms and Cyclooxygenase-2 Activation in the Effect of Desethylamiodarone on 4T1 Triple-Negative Breast Cancer Line.
Topics: Amiodarone; Animals; Antineoplastic Agents; Celecoxib; Cell Line, Tumor; Cell Movement; Cell Surviva | 2022 |